Bringing the fundamentals into focus…
Back to Voyager Therapeutics, Inc.
How Voyager Therapeutics, Inc. stacks up
VYGR · against 114 other Healthcare companies of similar size
Overall
23/ 100
Near the bottom of its peers.
Ranked #106 of 115 · scores higher than 8% of peers
Bars: peers in each 10-point band of the overall score13 peers with an overall score of 20–29, including VYGR · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around VYGR| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 592M ILS (≈$160M) | 84 | 99 | 99 | 96 | 1 / 2 | |
| 2 | 178.5B KRW (≈$129M) | 76 | 91 | 55 | 77 | 0 / 2 | |
| 2 | 6.5B TWD (≈$200M) | 76 | 83 | 78 | 56 | 0 / 2 | |
| 4 | 188M CHF (≈$216M) | 74 | 96 | 87 | 83 | 2 / 2 | |
| 5 | 1.1B HKD (≈$146M) | 72 | 99 | 53 | 80 | 1 / 2 | |
| 101 | 79M EUR (≈$87M) | 25 | 39 | 23 | 35 | 2 / 2 | |
| 103 | 736M HKD (≈$94M) | 24 | 6 | 39 | 2 / 2 | ||
| 103 | 201M USD | 24 | 8 | 48 | 29 | 2 / 2 | |
| 103 | 84M CAD (≈$61M) | 24 | 30 | 15 | 23 | 2 / 2 | |
| 106 | 113M USD | 23 | 8 | 10 | 7 | 0 / 2 | |
| 107 | 158M USD | 14 | 33 | 10 | 7 | 2 / 2 | |
| 108 | 118M USD | 13 | 8 | 23 | 18 | 2 / 2 | |
| 109 | 198M USD | 10 | 8 | 17 | 13 | 2 / 2 | |
| 109 | 149M USD | 10 | 0 | 1 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score